The SLC3 and SLC7 families of amino acid transporters

D Fotiadis, Y Kanai, M Palacín - Molecular aspects of medicine, 2013 - Elsevier
Amino acids are necessary for all living cells and organisms. Specialized transporters
mediate the transfer of amino acids across plasma membranes. Malfunction of these …

The L-type amino acid transporter LAT1—An emerging target in cancer

P Häfliger, RP Charles - International journal of molecular sciences, 2019 - mdpi.com
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are
highly dependent on nutrients in order to duplicate their cell mass during each cell division …

Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha

BN Chorley, MR Campbell, X Wang… - Nucleic acids …, 2012 - academic.oup.com
Cellular oxidative and electrophilic stress triggers a protective response in mammals
regulated by NRF2 (nuclear factor (erythroid-derived) 2-like; NFE2L2) binding to …

Integrins in the spotlight of cancer

D Bianconi, M Unseld, GW Prager - International journal of molecular …, 2016 - mdpi.com
Integrins are heterodimeric cell surface receptors that bind to different extracellular ligands
depending on their composition and regulate all processes which enable multicellular life. In …

CD98 at the crossroads of adaptive immunity and cancer

JM Cantor, MH Ginsberg - Journal of cell science, 2012 - journals.biologists.com
Adaptive immunity, a vertebrate specialization, adds memory and exquisite specificity to the
basic innate immune responses present in invertebrates while conserving metabolic …

Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer

K Kaira, Y Sunose, K Arakawa, T Ogawa… - British journal of …, 2012 - nature.com
Background: The expression of L-type amino-acid transporter 1 (LAT1) is tumour-specific
and has been shown to have essential roles in cell growth and survival. However, little is …

ASCT2 and LAT1 contribution to the hallmarks of cancer: from a molecular perspective to clinical translation

C Lopes, C Pereira, R Medeiros - Cancers, 2021 - mdpi.com
Simple Summary ASCT2 and LAT1 are amino acid transporters whose impact in cancer has
been explored throughout the years. They have been associated with most currently …

Silencing of intestinal glycoprotein CD98 by orally targeted nanoparticles enhances chemosensitization of colon cancer

B Xiao, E Viennois, Q Chen, L Wang, MK Han… - Acs Nano, 2018 - ACS Publications
Colon cancer is among the most widely occurring cancer types, leading to considerably high
mortality rate. The current chemotherapy achieves only limited success, and more effective …

[HTML][HTML] miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5

E Miko, Z Margitai, Z Czimmerer, I Várkonyi, B Dezső… - FEBS letters, 2011 - Elsevier
Despite intensive efforts to improve therapies, small cell lung cancer (SCLC) still has a
dismal median survival of 18 months. Since miR-126 is under-expressed in the majority of …

CD98 heavy chain as a prognostic biomarker and target for cancer treatment

P Xia, A Dubrovska - Frontiers in Oncology, 2023 - frontiersin.org
The SLC3A2 gene encodes for a cell-surface transmembrane protein CD98hc (4F2).
CD98hc serves as a chaperone for LAT1 (SLC7A5), LAT2 (SLC7A8), y+ LAT1 (SLC7A7), y+ …